[dnu] Communicating the Risk of Recurrence for Patients With HR+, HER2- Early Breast Cancer | VuMedi

Lilly Medical Affairs

[dnu] Communicating the Risk of Recurrence for Patients With HR+, HER2- Early Breast Cancer

By Lilly Medical Affairs FEATURING Joyce O’Shaughnessy

By Lilly Medical Affairs FEATURING Joyce O’Shaughnessy

3 views

August 1, 2024

VV-OTHR-US-DEL-XXXX © 2024 Lilly USA, LLC. All Rights Reserved.

Comments are disabled for this content.